Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| AFJK | Aimei Health Technology | $44.01 | $12.00 | 37.49% | 856K | $196M | $6.75$98.15 |
| SOC | Sable Offshore | $10.36 | $2.76 | 36.32% | 43.4M | $1.1B | $3.72$35.00 |
| ASTI | Ascent Solar Technologies | $5.06 | $1.18 | 30.41% | 31.1M | $13M | $1.10$7.40 |
| ASPC | A Spac III Acquisition Corp. | $16.10 | $3.66 | 29.42% | 714.8K | $29M | $9.95$63.98 |
| VUZI | Vuzix | $3.74 | $0.83 | 28.52% | 11.2M | $233M | $1.47$5.79 |
| OPTX | Syntec Optics | $2.49 | $0.52 | 26.40% | 94.1M | $73M | $1.02$4.51 |
| RAIL | FreightCar America | $10.85 | $1.81 | 20.02% | 692.7K | $172M | $4.31$13.64 |
| QBTZ | Tidal Trust II - Defiance Daily Target 2x Short Qbts ETF | $8.02 | $1.26 | 18.64% | 8.4M | - | $6.62$32.28 |
| RZLT | Rezolute | $2.42 | $0.37 | 18.05% | 13.8M | $190M | $1.07$11.46 |
| KXIN | Kaixin | $4.44 | $0.66 | 17.46% | 249.4K | $23M | $2.94$75.00 |
Related Articles
Featured Article
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
This Under-the-Radar Healthcare Stock Could Soar in 2026
Prosper Junior Bakiny|Sep 12, 2025
We should know a lot more by year-end.
Could Structure Therapeutics Become the Next Novo Nordisk?
Alex Carchidi|Jun 17, 2024
Becoming the next Novo Nordisk is a long shot, but it's more likely than it sounds.
Advertisement
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
Cory Renauer|Jun 11, 2024
Analysts who follow the start-up drugmaker think its stock has a chance to soar, but that doesn't mean it's right for you.
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Alex Carchidi|Jun 9, 2024
Structure Therapeutics has a long way to go before beating Wegovy.
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
Alex Carchidi|Dec 25, 2023
It has genuine struggles ahead, but it has some actual value in hand as well.
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
James Brumley|Nov 3, 2023
Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.
This Biotech Is Developing The Next Ozempic. Should You Buy It?
Alex Carchidi|Jun 16, 2023
If it succeeds, it'll still face a battle for market share.
Is It Too Late to Buy Vuzix Stock?
Leo Sun|Jun 16, 2023
Should you invest in this AR stock after its near-50% rally this year?
The Ultimate Growth Stocks To Buy With $1,000 Right Now
Leo Sun|Jun 14, 2022
Vuzix, Impinj, and Asana could all generate multibagger returns.
